Carolina Wealth Advisors »

Arrowhead Pharmaceuticals shares owned by Carolina Wealth Advisors

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Carolina Wealth Advisors from 13F filings

Historical chart of Carolina Wealth Advisors investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Carolina Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Carolina Wealth Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $12k 191 62.70

More positions owned by Carolina Wealth Advisors

Schwab Long-term U.s. Treasury Etf Etf (SCHQ)
Bny Mellon Us Large Cap Core Equity Etf Etf (BKLC)
Bny Mellon Core Bond Etf Etf (BKAG)
Schwab Us Tips Etf Etf (SCHP)
State Street Spdr Portfolio High Yield Bond Etf Etf (SPHY)
Invesco Bulletshares 2035 Corporate Bond Etf Etf (BSCZ)
Merck & Co Stock (MRK)
Gilead Sciences Stock (GILD)
Cisco Sys Stock (CSCO)
Southern Copper Corp Stock (SCCO)
Amgen Stock (AMGN)
Coca Cola Stock (KO)
Altria Group Stock (MO)
Fidelity Enhanced Small Cap Etf Etf (FESM)
Schwab International Dividend Equity Etf Etf (SCHY)

View all positions for Carolina Wealth Advisors

Top funds holding Arrowhead Pharmaceuticals

BlackRock
Vanguard Group
venBio Select Advisor
FMR
State Street Corporation
Geode Capital Management
Slate Path Capital
Baker Bros. Advisors
Arrowstreet Capital, Limited Partnership
Fred Alger Management
Deerfield Management Company
Driehaus Capital Management
Norges Bank Investment Management
Goldman Sachs Group
Siren

View all funds holding Arrowhead Pharmaceuticals